Boswell-Casteel Rebba C, Hays Franklin A
a Department of Biochemistry and Molecular Biology , University of Oklahoma Health Sciences Center , Oklahoma City , OK , USA.
b Stephenson Cancer Center , University of Oklahoma Health Sciences Center , Oklahoma City , OK , USA.
Nucleosides Nucleotides Nucleic Acids. 2017 Jan 2;36(1):7-30. doi: 10.1080/15257770.2016.1210805. Epub 2016 Oct 19.
Equilibrative nucleoside transporters (ENTs) are polytopic integral membrane proteins that mediate the transport of nucleosides, nucleobases, and therapeutic analogs. The best-characterized ENTs are the human transporters hENT1 and hENT2. However, non-mammalian eukaryotic ENTs have also been studied (e.g., yeast, parasitic protozoa). ENTs are major pharmaceutical targets responsible for modulating the efficacy of more than 30 approved drugs. However, the molecular mechanisms and chemical determinants of ENT-mediated substrate recognition, binding, inhibition, and transport are poorly understood. This review highlights findings on the characterization of ENTs by surveying studies on genetics, permeant and inhibitor interactions, mutagenesis, and structural models of ENT function.
平衡核苷转运体(ENTs)是多跨膜整合膜蛋白,介导核苷、核碱基和治疗性类似物的转运。研究最为深入的ENTs是人类转运体hENT1和hENT2。然而,非哺乳动物真核生物的ENTs也已得到研究(如酵母、寄生原生动物)。ENTs是主要的药物靶点,负责调节30多种已批准药物的疗效。然而,ENT介导的底物识别、结合、抑制和转运的分子机制及化学决定因素仍知之甚少。本综述通过考察遗传学、通透剂和抑制剂相互作用、诱变以及ENT功能的结构模型等方面的研究,突出了ENTs特性的研究发现。